(PEB) Pebblebrook Hotel Trust - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US70509V1008
Stock: Hotels, Resorts, Urban, Lifestyle, Lodging
Total Rating 30
Risk 34
Buy Signal 0.51
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.38% |
| Yield on Cost 5y | 0.20% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.1% |
| Payout Ratio | 126.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.3% |
| Relative Tail Risk | -5.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -24.92 |
| Character TTM | |
|---|---|
| Beta | 1.657 |
| Beta Downside | 1.617 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.43% |
| CAGR/Max DD | -0.14 |
Description: PEB Pebblebrook Hotel Trust January 19, 2026
Pebblebrook Hotel Trust (NYSE:PEB) is a publicly traded REIT that focuses on owning and operating urban and resort-style hotels in the United States. It currently holds 45 properties, roughly 12,000 guest rooms, spread across 13 key markets, making it the largest owner of lifestyle hotels in the country.
Key operational metrics that shape its outlook include an average occupancy rate of about 78 % in 2023, a RevPAR (Revenue per Available Room) growth of 5 % YoY, and a weighted-average lease-back term of 7 years, which together provide a relatively stable cash-flow profile. The business is highly sensitive to macro-drivers such as discretionary consumer spending, corporate travel demand, and the prevailing interest-rate environment, all of which influence both room rates and refinancing costs.
For a deeper quantitative assessment, you might explore ValueRay’s detailed analyst models on PEB to see how these drivers are priced into the stock.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -98.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.40 > 1.0 |
| NWC/Revenue: -7.78% < 20% (prev -10.14%; Δ 2.35% < -1%) |
| CFO/TA 0.05 > 3% & CFO 287.7m > Net Income -98.4m |
| Net Debt (2.35b) to EBITDA (239.0m): 9.83 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.6m) vs 12m ago -21.29% < -2% |
| Gross Margin: 23.74% > 18% (prev 0.26%; Δ 2349 % > 0.5%) |
| Asset Turnover: 25.97% > 50% (prev 25.33%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 0.09 > 6 (EBITDA TTM 239.0m / Interest Expense TTM 95.8m) |
Altman Z'' -1.51
| A: -0.02 (Total Current Assets 277.8m - Total Current Liabilities 391.7m) / Total Assets 5.55b |
| B: -0.27 (Retained Earnings -1.48b / Total Assets 5.55b) |
| C: 0.00 (EBIT TTM 8.73m / Avg Total Assets 5.64b) |
| D: -0.50 (Book Value of Equity -1.47b / Total Liabilities 2.95b) |
| Altman-Z'' Score: -1.51 = D |
Beneish M -4.00
| DSRI: 0.74 (Receivables 45.7m/61.0m, Revenue 1.46b/1.45b) |
| GMI: 1.08 (GM 23.74% / 25.67%) |
| AQI: -0.38 (AQ_t -0.01 / AQ_t-1 0.02) |
| SGI: 1.01 (Revenue 1.46b / 1.45b) |
| TATA: -0.07 (NI -98.4m - CFO 287.7m) / TA 5.55b) |
| Beneish M-Score: -4.05 (Cap -4..+1) = AAA |
What is the price of PEB shares?
As of February 07, 2026, the stock is trading at USD 12.38 with a total of 2,241,987 shares traded.
Over the past week, the price has changed by +8.41%, over one month by +4.65%, over three months by +18.91% and over the past year by -3.22%.
Over the past week, the price has changed by +8.41%, over one month by +4.65%, over three months by +18.91% and over the past year by -3.22%.
Is PEB a buy, sell or hold?
Pebblebrook Hotel Trust has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold PEB.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the PEB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.9 | 3.9% |
| Analysts Target Price | 12.9 | 3.9% |
| ValueRay Target Price | 12.8 | 3.2% |
PEB Fundamental Data Overview February 03, 2026
P/E Forward = 24.57
P/S = 0.9249
P/B = 0.5205
P/EG = 0.48
Revenue TTM = 1.46b USD
EBIT TTM = 8.73m USD
EBITDA TTM = 239.0m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 17.2m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.35b USD (from netDebt column, last quarter)
Enterprise Value = 3.70b USD (1.35b + Debt 2.57b - CCE 223.2m)
Interest Coverage Ratio = 0.09 (Ebit TTM 8.73m / Interest Expense TTM 95.8m)
EV/FCF = 10.00x (Enterprise Value 3.70b / FCF TTM 370.4m)
FCF Yield = 10.00% (FCF TTM 370.4m / Enterprise Value 3.70b)
FCF Margin = 25.30% (FCF TTM 370.4m / Revenue TTM 1.46b)
Net Margin = -6.72% (Net Income TTM -98.4m / Revenue TTM 1.46b)
Gross Margin = 23.74% ((Revenue TTM 1.46b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 26.15% (prev 29.39%)
Tobins Q-Ratio = 0.67 (Enterprise Value 3.70b / Total Assets 5.55b)
Interest Expense / Debt = 0.78% (Interest Expense 20.2m / Debt 2.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = 6.90m (EBIT 8.73m * (1 - 21.00%))
Current Ratio = 0.71 (Total Current Assets 277.8m / Total Current Liabilities 391.7m)
Debt / Equity = 1.02 (Debt 2.57b / totalStockholderEquity, last quarter 2.51b)
Debt / EBITDA = 9.83 (Net Debt 2.35b / EBITDA 239.0m)
Debt / FCF = 6.34 (Net Debt 2.35b / FCF TTM 370.4m)
Total Stockholder Equity = 2.62b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.75% (Net Income -98.4m / Total Assets 5.55b)
RoE = -3.76% (Net Income TTM -98.4m / Total Stockholder Equity 2.62b)
RoCE = 0.18% (EBIT 8.73m / Capital Employed (Equity 2.62b + L.T.Debt 2.22b))
RoIC = 0.14% (NOPAT 6.90m / Invested Capital 4.87b)
WACC = 4.55% (E(1.35b)/V(3.93b) * Re(12.02%) + D(2.57b)/V(3.93b) * Rd(0.78%) * (1-Tc(0.21)))
Discount Rate = 12.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.76%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈274.1m ; Y1≈338.1m ; Y5≈575.8m
Fair Price DCF = 126.9 (EV 16.77b - Net Debt 2.35b = Equity 14.42b / Shares 113.6m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 0.97 | EPS CAGR: 30.73% | SUE: 1.78 | # QB: 1
Revenue Correlation: -41.47 | Revenue CAGR: 13.59% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.36 | Chg30d=+0.002 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.54 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+23.9% | Growth Revenue=-0.7%
P/S = 0.9249
P/B = 0.5205
P/EG = 0.48
Revenue TTM = 1.46b USD
EBIT TTM = 8.73m USD
EBITDA TTM = 239.0m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 17.2m USD (from shortTermDebt, last quarter)
Debt = 2.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.35b USD (from netDebt column, last quarter)
Enterprise Value = 3.70b USD (1.35b + Debt 2.57b - CCE 223.2m)
Interest Coverage Ratio = 0.09 (Ebit TTM 8.73m / Interest Expense TTM 95.8m)
EV/FCF = 10.00x (Enterprise Value 3.70b / FCF TTM 370.4m)
FCF Yield = 10.00% (FCF TTM 370.4m / Enterprise Value 3.70b)
FCF Margin = 25.30% (FCF TTM 370.4m / Revenue TTM 1.46b)
Net Margin = -6.72% (Net Income TTM -98.4m / Revenue TTM 1.46b)
Gross Margin = 23.74% ((Revenue TTM 1.46b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 26.15% (prev 29.39%)
Tobins Q-Ratio = 0.67 (Enterprise Value 3.70b / Total Assets 5.55b)
Interest Expense / Debt = 0.78% (Interest Expense 20.2m / Debt 2.57b)
Taxrate = 21.0% (US default 21%)
NOPAT = 6.90m (EBIT 8.73m * (1 - 21.00%))
Current Ratio = 0.71 (Total Current Assets 277.8m / Total Current Liabilities 391.7m)
Debt / Equity = 1.02 (Debt 2.57b / totalStockholderEquity, last quarter 2.51b)
Debt / EBITDA = 9.83 (Net Debt 2.35b / EBITDA 239.0m)
Debt / FCF = 6.34 (Net Debt 2.35b / FCF TTM 370.4m)
Total Stockholder Equity = 2.62b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.75% (Net Income -98.4m / Total Assets 5.55b)
RoE = -3.76% (Net Income TTM -98.4m / Total Stockholder Equity 2.62b)
RoCE = 0.18% (EBIT 8.73m / Capital Employed (Equity 2.62b + L.T.Debt 2.22b))
RoIC = 0.14% (NOPAT 6.90m / Invested Capital 4.87b)
WACC = 4.55% (E(1.35b)/V(3.93b) * Re(12.02%) + D(2.57b)/V(3.93b) * Rd(0.78%) * (1-Tc(0.21)))
Discount Rate = 12.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.76%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈274.1m ; Y1≈338.1m ; Y5≈575.8m
Fair Price DCF = 126.9 (EV 16.77b - Net Debt 2.35b = Equity 14.42b / Shares 113.6m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 0.97 | EPS CAGR: 30.73% | SUE: 1.78 | # QB: 1
Revenue Correlation: -41.47 | Revenue CAGR: 13.59% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.36 | Chg30d=+0.002 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.54 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+23.9% | Growth Revenue=-0.7%